| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |